The international pharmaceutical company MSD and the Russian company Fort agreed to cooperate in the phased localization of the rotavirus infection, chicken pox, and human papillomavirus (HPV) prevention vaccine production. Investments will amount to RUB 7 billion. This is stated in a joint statement by the companies.
Novartis Pharma, a Swiss company, is ready to invest 3.5 billion rubles in the creation of anti-cancer medicines production in the Ryazan Region. This was announced by Nikolay Lyubimov, Governor of the Ryazan Region, on Wednesday in his message about the regional priorities.
Russian foods and food ingredients company Aston and transnational company Archer Daniels Midland Company (NYSE: ADM) launched a joint venture for the production starch and syrups in the village of Ibred in the Ryazan Region. This was reported by the press service of Aston.
Scopinpharm plans to invest about 4 billion rubles in a platform for deep localization of the production of six innovative oncological and hematological drugs from Novartis, Inga Nizharadze, the Director General of Scopinpharm said. The Swiss company, in turn, will provide technology transfer.
The world's largest chocolate manufacturer, Swiss Barry Callebaut, will almost triple its capacities in Russia. Company believes that Russian market has huge potential.
Nikolay Lubimov signed a cooperation agreement between the government of the Ryazan Oblast and Wingflow AG (Switzerland), says the press-office of the regional government. Under the agreement, a plant will be constructed in the territory of the region for production of high-tech components for the chemical and pharma industry.
The investments are expected to amount to RUB 2,287 mln. The facility creating 36 new jobs is expected to open in 2020.